
|Articles|March 10, 2008
Latebreakers: Dual anti-cholesterol niacin/statin combo granted approval
NiaSpan and simvastatin combination approved for cholesterol lowering.
Advertisement
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
REM-Dominant Sleep Apnea Is Significantly More Prominent Following COVID-19
2
Trump Executive Order Set to Reclassify Marijuana, Improve CBD Access
3
Most Favored Nation: Global Benchmarking to Reimagine US Drug Distribution
4
From Policy to Practice: Elevating Pharmacy’s Role in Quality and Patient Safety
5






















































































































